Autonomix Medical Inc stock is traded at $1.70, with a volume of 178,328. It is up +11.84% in the last 24 hours and down -45.34% over the past month. Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
Previous Close:
$1.52
Open:
$1.57
24h Volume:
178,328
Relative Volume:
2.34
Market Cap:
$3.33M
Revenue:
-
Net Income/Loss:
-$16.72M
P/E Ratio:
-
EPS:
-$64.03
Net Cash Flow:
-$12.29M
1W Performance:
+1.19%
1M Performance:
-45.34%
6M Performance:
-76.87%
1Y Performance:
-89.82%
1-Day Range:
$1.53$1.77
1-Week Range:
$1.46$1.78
52-Week Range:
$1.46$32.55
Autonomix Medical Inc Stock (AMIX) Company Profile
Name
Autonomix Medical IncSector
HealthcareIndustry
Medical DevicesPhone
832-277-7816Address
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS